Dr. Reddy's Recalls Flucanazole Tablets for Dissolution Failures
Dr. Reddy's is recalling Flucanazole tablets that failed dissolution and stability specifications. Patients should stop using the affected lots and consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II due to failure of dissolution and stability specifications, which poses a risk of harm but is not classified as Class I (reasonable probability of serious adverse health consequences or death).
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Flucanazole Tablets, USP, 100 mg, in 30-count and 100-count bottles. The recall is due to the product failing dissolution specifications and an 18-month stability time point. The affected products are prescription-only and were distributed nationwide.
The specific lots involved are 30-count bottles with codes C500224 (exp 12/2016) and C500846 (exp 01/2017), and 100-count bottles with codes C500224 (exp 12/2016), C501608 (exp 02/2017), and C503655 (exp 04/2017). The total quantity recalled is 42,984 30-count bottles and 7,764 100-count bottles.
Patients who have these specific lots should stop using them and consult their healthcare provider for an alternative treatment. The FDA has classified this recall as Class II, meaning there is a reasonable probability that the use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- FLUCONAZOLE (FLUCONAZOLE)
- Brand
- FLUCONAZOLE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Antifungal
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- a) 30 count C500224
- exp 12/2016
- C500846
- exp 01/2017 b) 100 count C500224
- C501608
- exp 02/2017 and C503655
- exp 04/2017
UPCs (1)
- 0355111145127
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · FLUCONAZOLE
- SevereBaxter Recalls Fluconazole Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- ModerateHarvard Drug Group Recalls Fluconazole Tablets for Failed Dissolution
FDA (Drugs) · 2017-05-10
- ModerateFluconazole Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2017-05-10
- ModerateDr. Reddy's Recalls Flucanazole Tablets for Dissolution Failures
FDA (Drugs) · 2017-02-08
- ModerateDr. Reddy's Recalls Flucanazole Tablets Due to Dissolution Failures
FDA (Drugs) · 2017-02-08
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModerateMinocycline extended-release tablets failed dissolution testing during stability analysis
FDA (Drugs) · 2026-06-17